Search Within

Advanced Practice Providers

  1. "Stem Cell Transplantation and Cellular Therapy Service "
Formats
  1. Meeting Abstract (53)
  2. Journal Article (28)
  3. Research Letter (1)
Groups
  1. Pediatrics, Department of (82)
  2. Stem Cell Transplantation and Cellular Therapy Service (82)
  3. Department of Medicine (75)
  4. Nursing (75)
  5. Center for Hematologic Malignancies (62)
  6. GSK Faculty (52)

More Groups

People
  1. Nancy Kernan (45)
  2. Farid Boulad (39)
  3. Andromachi Scaradavou (37)
  4. Richard O'Reilly (37)
  5. Susan Prockop (26)
  6. Kevin Curran (25)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Blood (28)
  2. Biology of Blood and Marrow Transplantation (21)
  3. Bone Marrow Transplantation (7)
  4. Pediatric Blood and Cancer (5)
  5. Journal of Clinical Oncology (3)
  6. Pediatric Hematology and Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (23)
  3. Nature Publishing Group (10)
  4. Wiley Periodicals, Inc (5)
  5. American Society of Clinical Oncology (3)
  6. Taylor & Francis Group (2)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective evaluation of cord blood (CB) & haplo-identical donor availability reveals compromised donor access for both graft types in minorities and high rates of failure to clear haplo donors in adult patients
    Meeting Abstract

    Kosuri, S.; Wolff, T. F.; Byam, C.; Lauer, E.; Yoo, Y.; Perales, M. A.; Giralt, S. A.; Scaradavou, A.; Ponce, D. M.; Barker, J. N.
    Blood (2015)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies
    Journal Article

    Shah, G. L.; Shune, L.; Purtill, D.; Devlin, S.; Lauer, E.; Lubin, M.; Bhatt, V.; McElrath, C.; Kernan, N. A.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells from HLA-partially matched normal donors to induce durable remissions of rituximab refractory EBV(+) B-cell lymphomas post hematopoietic and organ allografts
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C. S.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning
    Meeting Abstract

    Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Blood (2014)

    Fulltext@MSK | Save